Refractory acquired thrombotic thrombocytopenic purpura in a patient with sickle cell trait successfully treated with caplacizumab.

Saved in:
Bibliographic Details
Title: Refractory acquired thrombotic thrombocytopenic purpura in a patient with sickle cell trait successfully treated with caplacizumab.
Authors: Aggarwal V; College of Medicine, University of Saskatchewan, Regina, Canada., Singer Z; College of Medicine, University of Saskatchewan, Regina, Canada., Ledingham D; Saskatchewan Health Authority and College of Medicine, University of Saskatchewan, Regina, Canada., Othman I; Allan Blair Cancer Centre, College of Medicine, University of Saskatchewan, Regina, Canada.
Source: Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 590-593.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1607-8454
DOI:10.1080/16078454.2021.1959984